Author:
Sandborn William J.,Ghosh Subrata,Panes Julian,Vranic Ivana,Wang Wenjin,Niezychowski Wojciech,Vermeire Severine A.R.A.,Dewit Olivier,Peeters Harald,Stehlik Jiri,Vanasek Tomas,Laharie David,Colombel Jean Frederic,Bigard Marc-André,Varga Marta,Zeher Margit,Novak Janos,Hunyady Bela,Salamon Agnes,Racz Istvan,Gionchetti Paolo,Kohn Anna,Prantera Cosimo,Stokkers P.C.F.,Slomka Maria,Paradowski Leszek,Arlukowicz Tomasz,Kuzela Ladislav,Baricky Boris,Hlavaty Tibor,Vera Maria Isabel,Panes Julian,Guardiola Jordi,Probert Christopher,Shaffer Jonathan Lionel,Fleisher Mark,Pruitt Ronald Edward,Sandborn William J.,Goff John Sawyer,Weber John,Bell Raymond Lloyd,Zwick Andrew Harrison,Gutierrez Alexandra,Levine Robert H.,Hanauer Stephen Brett,Lavelle Lori Ann,Kottoor Ravindranath K.,Dryden Gerald Wayne,Hardi Robert,Glorioso David Vaughn,Swaroop Prabhakar,Lee Scott D.,Patrick Teressa Joan,Scheinert Sheldon,Sninsky Charles A.,Katz Seymour,Noar Mark D.,Gaspari Michael Marion,Gordon Glenn L.,Dalton Thomas A.,Homoky Douglas Edward,Kilgore William Ransom,Levien Joel A.,Schneider Herbert R.,Moola Suleman Abdul,Kruger Frederik Cornelius,Wright John P.,Aboo Nazimuddin
Subject
Gastroenterology,Hepatology
Reference16 articles.
1. Crohn's disease;Baumgart;Lancet,2012
2. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease;Lichtenstein;Gastroenterology,2006
3. A qualitive analysis of kinase inhibitor selectivity;Karaman;Nat Biotechnol,2008
4. Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis;Meyer;J Inflamm,2010
5. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis;Fleischmann;N Engl J Med,2012